# OnCo record t-cell-engager (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/t-cell-engager/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "t-cell-engager" ;
  schema:name "T-cell engagers (bispecific)"@en ;
  schema:description "An off-the-shelf drug that physically links a killer T cell to a cancer cell, forcing the attack."@en ;
  schema:url <https://onco.cc/technologies/t-cell-engager/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Bi-specific_T-cell_engager> ;
  schema:citation <https://en.wikipedia.org/wiki/Bi-specific_T-cell_engager> ;
  onco:status "approved" ;
  onco:related <https://onco.cc/technologies/nk-cell-engagers/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:targets <https://onco.cc/targets/cd3/>, <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/cd20/>, <https://onco.cc/targets/bcma/>, <https://onco.cc/targets/gprc5d/>, <https://onco.cc/targets/dll3/>, <https://onco.cc/targets/gp100/>, <https://onco.cc/targets/psma/> ;
  onco:drugs <https://onco.cc/drugs/tarlatamab/>, <https://onco.cc/drugs/teclistamab/>, <https://onco.cc/drugs/glofitamab/>, <https://onco.cc/drugs/tebentafusp/>, <https://onco.cc/drugs/blinatumomab/> ;
  onco:companies <https://onco.cc/companies/xencor/>, <https://onco.cc/companies/amunix-pharmaceuticals/>, <https://onco.cc/companies/cullinan-therapeutics/>, <https://onco.cc/companies/cytomx-therapeutics/>, <https://onco.cc/companies/enlaza-therapeutics/>, <https://onco.cc/companies/harpoon-therapeutics/>, <https://onco.cc/companies/igm-biosciences/>, <https://onco.cc/companies/janux-therapeutics/>, <https://onco.cc/companies/marengo-therapeutics/> ;
  onco:terms <https://onco.cc/terms/crs/> ;
  onco:dependsOn <https://onco.cc/technologies/bispecific-antibody/> .